Fernanda Paiva Augusto Rodrigues
Research Subjects
Research Interests
Fernanda Paiva Augusto Rodrigues has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Chiara Maria de Brito Tischer
School of Medical Sciences, Santa Casa of Sao Paulo, Sao Paulo, Brazil
1 shared publication - Jean Goncalves de Oliveira
Division of Neurosurgery, Department of Surgery, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP) and Santa Casa de São Paulo School of Medical Sciences (FCMSCSP), São Paulo, SP, Brazil
1 shared publication - José Carlos Esteves Veiga
Division of Neurosurgery, Department of Surgery, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP) and Santa Casa de São Paulo School of Medical Sciences (FCMSCSP), São Paulo-SP, Brazil
1 shared publication - José Roberto Tude Melo
Division of Neurosurgery, Department of Surgery, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP) and Santa Casa de São Paulo School of Medical Sciences (FCMSCSP), São Paulo-SP, Brazil
1 shared publication - Júlia Calviello Giordano
Santa Casa de São Paulo School of Medical Sciences (FCMSCSP), São Paulo-SP, Brazil
1 shared publication - Larissa Ferreira Gomes de Oliveira
School of Medical Sciences, Santa Casa of Sao Paulo, Sao Paulo, Brazil
1 shared publication
Latest Publications
- 11 June 2024
- Published by Springer Nature in Child's Nervous System
- Vol. 40 (9) , 2781-2787
Accuracy of acute hyperglycemia as a biomarker of severe brain damage in children with traumatic brain injury
Purpose Biomarkers are substances measured at the systemic level to evaluate organic responses in certain situations, establishing diagnoses, disease staging, and prognosis. Blood glucose is a biomarker recognized as a predictor of prognosis in children victims of traumatic brain injury (TBI). The scope of this study was to identify the accuracy of blood glucose as a biomarker of severe brain injury. Methods A retrospective analytical study was conducted through the consecutive review of medical records of children and teenage victims of TBI who underwent neurological surgery between 2016 and 2023 in a level 1 trauma center. Two groups were compared: children with Glasgow Coma Scale (GCS) score ≤ 8 and children with GCS > 8. We calculated the predictive values to define the accuracy of blood glucose as a biomarker of brain injury. Results Ninety-two medical records were included for analysis. Hyperglycemia predominated in cases with GCS ≤ 8 (48% vs 3%; p < 0.0001; OR, 30; 95% CI, 5.9902–150.2448). The glycemic measurement considering the cutoff point of 200 mg/dL or 11.1 mmol/L showed a specificity of 97%, a positive predictive value of 86%, an accuracy of 84%, and a likelihood ratio for a positive test of 16. Conclusion Victims with GCS ≤ 8 are 16 times more likely to develop acute hyperglycemia after TBI when compared to those with GCS > 8. Blood glucose is a biomarker with an accuracy of 84% to predict severe brain injury, considering the cutoff point of 200 mg/dL or 11.1 mmol/L.
- 11 June 2024
- Published by Springer Nature in Child's Nervous System
- Vol. 40 (9) , 2781-2787
Accuracy of acute hyperglycemia as a biomarker of severe brain damage in children with traumatic brain injury
Purpose Biomarkers are substances measured at the systemic level to evaluate organic responses in certain situations, establishing diagnoses, disease staging, and prognosis. Blood glucose is a biomarker recognized as a predictor of prognosis in children victims of traumatic brain injury (TBI). The scope of this study was to identify the accuracy of blood glucose as a biomarker of severe brain injury. Methods A retrospective analytical study was conducted through the consecutive review of medical records of children and teenage victims of TBI who underwent neurological surgery between 2016 and 2023 in a level 1 trauma center. Two groups were compared: children with Glasgow Coma Scale (GCS) score ≤ 8 and children with GCS > 8. We calculated the predictive values to define the accuracy of blood glucose as a biomarker of brain injury. Results Ninety-two medical records were included for analysis. Hyperglycemia predominated in cases with GCS ≤ 8 (48% vs 3%; p < 0.0001; OR, 30; 95% CI, 5.9902–150.2448). The glycemic measurement considering the cutoff point of 200 mg/dL or 11.1 mmol/L showed a specificity of 97%, a positive predictive value of 86%, an accuracy of 84%, and a likelihood ratio for a positive test of 16. Conclusion Victims with GCS ≤ 8 are 16 times more likely to develop acute hyperglycemia after TBI when compared to those with GCS > 8. Blood glucose is a biomarker with an accuracy of 84% to predict severe brain injury, considering the cutoff point of 200 mg/dL or 11.1 mmol/L.